Skip to main content

Loading...

Home
About
Products
Science and Pipeline
Investors and media
Collaborations
Contact Us

Products

subtitle

Home / products

/sites/default/files/video/products_banner.mp4

elfabrio

For the treatment of adult patients with Fabry Disease
First approved in May 2023

elelyso

For the treatment of Gaucher Disease
First approved in May 2012

in
Investors
About
Site Map
Privacy Policy
Terms of use

© 2024 Protalix Biotherapeutics Inc.

You are about to leave the Protalix BioTherapeutics, Inc. website.
Links to other websites are provided for general informational purposes only Protalix BioTherapeutics, Inc.
assumes no responsibility for information you may encounter on websites that are not owned or operated by Protalix BioTherapeutics, Inc.